0001209191-11-041036.txt : 20110726 0001209191-11-041036.hdr.sgml : 20110726 20110726213447 ACCESSION NUMBER: 0001209191-11-041036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110725 FILED AS OF DATE: 20110726 DATE AS OF CHANGE: 20110726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beck John W CENTRAL INDEX KEY: 0001292404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33734 FILM NUMBER: 11988609 MAIL ADDRESS: STREET 1: C/O METABASIS THERAPEUTICS STREET 2: 9390 TOWNE CENTRE DRIVE, BLDG 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE CENTRAL INDEX KEY: 0001103390 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943200380 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-652-6500 MAIL ADDRESS: STREET 1: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE DATE OF NAME CHANGE: 20000127 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-07-25 0 0001103390 Ardea Biosciences, Inc./DE RDEA 0001292404 Beck John W 4939 DIRECTORS PLACE SAN DIEGO CA 92121 0 1 0 0 SVP, Finance & Operations, CFO Common Stock 2011-07-25 4 M 0 16000 14.26 A 20409 D Common Stock 2011-07-25 4 S 0 16000 24.4632 D 4409 D Employee Stock Option (Right to Buy) 14.26 2011-07-25 4 M 0 16000 0.00 D 2018-05-26 Common Stock 16000 184000 D The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 23, 2011. The range of sales prices received was $24.31 to $24.72. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. 25% of the shares subject to the stock option vest and become exercisable on May 27, 2009. The remaining shares vest in equal monthly installments over the following 3 years. /s/ John W. Beck 2011-07-26